Matthew K. Fust

2007

In 2007, Matthew K. Fust earned a total compensation of $698.1K as Former Chief Financial Officer at Jazz Pharmaceuticals, a 11% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$100,000
Option Awards$256,703
Salary$340,850
Other$554
Total$698,107

Fust received $340.9K in salary, accounting for 49% of the total pay in 2007.

Fust also received $100K in non-equity incentive plan, $256.7K in option awards and $554 in other compensation.

Rankings

In 2007, Matthew K. Fust's compensation ranked 5,104th out of 8,700 executives tracked by ExecPay. In other words, Fust earned more than 41.3% of executives.

ClassificationRankingPercentile
All
5,104
out of 8,700
41st
Division
Manufacturing
1,885
out of 3,314
43rd
Major group
Chemicals And Allied Products
389
out of 746
48th
Industry group
Drugs
246
out of 546
55th
Industry
Pharmaceutical Preparations
176
out of 364
52nd
Source: SEC filing on October 23, 2009.

Fust's colleagues

We found four more compensation records of executives who worked with Matthew K. Fust at Jazz Pharmaceuticals in 2007.

2007

Samuel Saks

Jazz Pharmaceuticals

Chief Executive Officer

2007

Robert Myers

Jazz Pharmaceuticals

President

2007

Bruce Cozadd

Jazz Pharmaceuticals

Chief Executive Officer

2007

Carol Gamble

Jazz Pharmaceuticals

General Counsel

You may also like